OOIR: Observatory of International Research

Papers

(The H4-Index of World Psychiatry is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Increased risk of COVID‐19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States	441
A meta‐review of “lifestyle psychiatry”: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders	409
Perinatal mental health: a review of progress and challenges	399
The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality	333
Addressing mental health needs: an integral part of COVID‐19 response	309
Anxiety and depression among general population in China at the peak of the COVID‐19 epidemic	271
Adaptation of evidence‐based suicide prevention strategies during and after the COVID‐19 pandemic	185
Validation of the new DSM‐5‐TR criteria for prolonged grief disorder and the PG‐13‐Revised (PG‐13‐R) scale	183
Preventive psychiatry: a blueprint for improving the mental health of young people	175
The clinical characterization of the adult patient with depression aimed at personalization of management	169
The promise of machine learning in predicting treatment outcomes in psychiatry	165
Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic met	162
The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses	155
Designing and scaling up integrated youth mental health care	153
Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors	150
Assessing the public health impacts of legalizing recreational cannabis use: the US experience	149
Transdiagnostic clinical staging in youth mental health: a first international consensus statement	149
The clinical characterization of the patient with primary psychosis aimed at personalization of management	144
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum	142
What is resilience: an affiliative neuroscience approach	141
Preventing suicide in the context of the COVID‐19 pandemic	134
Psychotherapies for depression: a network meta‐analysis covering efficacy, acceptability and long‐term outcomes of all main treatment types	131
Risk and protective factors for mental disorders beyond genetics: an evidence‐based atlas	122
Psychiatry in the age of COVID‐19	116
Hierarchical models of psychopathology: empirical support, implications, and remaining issues	104

COVID‐19 and psychiatrists' responsibilities: a WPA position paper	102
An organization‐ and category‐level comparison of diagnostic requirements for mental disorders in ICD‐11 and DSM‐5	96
Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double‐blind randomized controlled trial	95
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum	93
The clinical significance of duration of untreated psychosis: an umbrella review and random‐effects meta‐analysis	92
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021	92
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): II. Externalizing superspectrum	91
The relevance of COVID‐19 pandemic to psychiatry	84
Prioritizing COVID‐19 vaccination for people with severe mental illness	81
“Third‐wave” cognitive and behavioral therapies and the emergence of a process‐based approach to intervention in psychiatry	80
Differential impact of COVID‐related lockdown on mental health in Germany	76
Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review	74
COVID‐19 health anxiety	70
Nature and prevalence of combinations of mental disorders and their association with excess mortality in a population‐based cohort study	70
Psychological processes mediating the association between developmental trauma and specific psychotic symptoms in adults: a systematic review and meta‐analysis	69
Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration	69
PHQ‐9: global uptake of a depression scale	68
Emerging experience with selected new categories in the ICD‐11: complex PTSD, prolonged grief disorder, gaming disorder, and compulsive sexual behaviour disorder	65
The lived experience of psychosis: a bottom‐up review co‐written by experts by experience and academics	64
Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta‐analysis	63
A pandemic of social isolation?	62
An update on Individual Placement and Support	62
The unified protocol for transdiagnostic treatment of emotional disorders	61
The Horyzons project: a randomized controlled trial of a novel online social therapy to maintain treatment effects from specialist first‐episode psychosis services	60
Association of preceding psychosis risk states and non‐psychotic mental disorders with incidence of clinical psychosis in the general population: a prospective study in the NEMESIS‐2 cohort	50